Qufeng Xuanbi Formula shows potential in treating allergic asthma via immune-metabolic regulation
Qufeng Xuanbi Formula has demonstrated anti-asthmatic activity and may influence airway remodeling through metabolic pathways.
Asset / Drug
Drug and asset intelligence for Qufeng with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.